Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike L Pahl

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Seminars in Hematology|October 8, 2005
Chromosomal abnormalities and molecular markers in myeloproliferative disordersAnthony J Bench, Heike L Pahl
Mediators of Inflammation|November 7, 2015
The Hen or the Egg: Inflammatory Aspects of Murine MPN ModelsJonas S Jutzi, Heike L Pahl
Human Pathology|April 4, 2016
Immunohistochemical staining of transcription factor NFE2 for the discrimination of primary myelofibrosis from essential thrombocythemiaKonrad Aumann, Martin Werner, Heike L Pahl
Annals of Hematology|May 27, 2009
Clinical and hematological presentation of children and adolescents with polycythemia veraHolger Cario, Mary Frances McMullin, Heike L Pahl
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
Ponatinib: a third-generation inhibitor for the treatment of CMLJulius Wehrle, Heike L Pahl, Nikolas von Bubnoff
Haematologica|June 22, 2014
NFE2 regulates transcription of multiple enzymes in the heme biosynthesis pathwayLara Rheinemann, Thalia S Seeger, Julius Wehrle, et al.
Leukemia|March 27, 2025
Malignant JAK-signaling: at the interface of inflammation and malignant transformationFlorian Perner, Heike L Pahl, Robert Zeiser, et al.
Experimental Hematology|August 6, 2010
Of mice and men: human RNA polymerase III promoter U6 is more efficient than its murine homologue for shRNA expression from a lentiviral vector in both human and murine progenitor cellsRoland Roelz, Ingo H Pilz, Manuel Mutschler, et al.
Blood|March 27, 2010
AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2Wei Wang, Sven Schwemmers, Elizabeth O Hexner, et al.
Hemasphere|May 6, 2021
Pharmacological Inhibition of Insulin Growth Factor-1 Receptor (IGF-1R) Alone or in Combination With Ruxolitinib Shows Therapeutic Efficacy in Preclinical Myeloproliferative Neoplasm ModelsTitiksha Basu, Hannah Bertrand, Nikolaos Karantzelis, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Seminars in Hematology|October 8, 2005
Chromosomal abnormalities and molecular markers in myeloproliferative disordersAnthony J Bench, Heike L Pahl
Mediators of Inflammation|November 7, 2015
The Hen or the Egg: Inflammatory Aspects of Murine MPN ModelsJonas S Jutzi, Heike L Pahl
Human Pathology|April 4, 2016
Immunohistochemical staining of transcription factor NFE2 for the discrimination of primary myelofibrosis from essential thrombocythemiaKonrad Aumann, Martin Werner, Heike L Pahl
Annals of Hematology|May 27, 2009
Clinical and hematological presentation of children and adolescents with polycythemia veraHolger Cario, Mary Frances McMullin, Heike L Pahl
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
Ponatinib: a third-generation inhibitor for the treatment of CMLJulius Wehrle, Heike L Pahl, Nikolas von Bubnoff
Haematologica|June 22, 2014
NFE2 regulates transcription of multiple enzymes in the heme biosynthesis pathwayLara Rheinemann, Thalia S Seeger, Julius Wehrle, et al.
Leukemia|March 27, 2025
Malignant JAK-signaling: at the interface of inflammation and malignant transformationFlorian Perner, Heike L Pahl, Robert Zeiser, et al.
Experimental Hematology|August 6, 2010
Of mice and men: human RNA polymerase III promoter U6 is more efficient than its murine homologue for shRNA expression from a lentiviral vector in both human and murine progenitor cellsRoland Roelz, Ingo H Pilz, Manuel Mutschler, et al.
Blood|March 27, 2010
AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2Wei Wang, Sven Schwemmers, Elizabeth O Hexner, et al.
Hemasphere|May 6, 2021
Pharmacological Inhibition of Insulin Growth Factor-1 Receptor (IGF-1R) Alone or in Combination With Ruxolitinib Shows Therapeutic Efficacy in Preclinical Myeloproliferative Neoplasm ModelsTitiksha Basu, Hannah Bertrand, Nikolaos Karantzelis, et al.
Pageof 10